| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $784K | -8.8% |
| Cost of Revenue | $554K | -13.8% |
| Gross Profit | $230K | +6.0% |
| R&D Expense | $14K | -26.3% |
| SG&A Expense | $4.0M | +12.7% |
| Operating Income | -$3.7M | -12.9% |
| Pre-tax Income | -$2.3M | -55.0% |
| Income Tax | $0 | — |
| Net Income | -$2.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.2M | +19.3% |
| Accounts Receivable | $91K | +2.2% |
| Inventory | $46K | -34.3% |
| Current Assets | $13.5M | -16.1% |
| Total Assets | $29.1M | -4.2% |
| Current Liabilities | $1.5M | +21.3% |
| Total Liabilities | $2.0M | +61.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.8M | -137.9% |
| Capital Expenditures | $4K | — |
| Investing Cash Flow | $3.9M | +333.3% |
| Free Cash Flow | -$2.8M | -138.2% |
| -55.0% |
| EPS (Basic) | $0.00 | — |
| Stockholders' Equity |
| $27.1M |
| -7.0% |